Frontiers in Immunology · 2024 · 17 citations · 43 references
MedicineOncologyPharmacologyImmunoregulationInflammationMolecular OncologyCancer ImmunotherapyCytokine-based TherapyCytokines In Tumor ImmunityInflammatory SignalingInterferon ResponsesLiver MetastasisAdeno-associated Viral VectorsAdenovirus VectorsHepatocellular Carcinoma TreatmentLiver Tumor TherapySystemic DeliveryT Cell Cytokine ProductionTissue-specific Expression VectorsVector Dose Optimization
Hepatocellular carcinoma (HCC) and solid cancers with liver metastases are indications with high unmet medical need. Interleukin-12 (IL-12) is a proinflammatory cytokine with substantial anti-tumor properties, but its therapeutic potential has not been realized due to severe toxicity. Here, we show that orthotopic liver tumors in mice can be treated by targeting hepatocytes via systemic delivery of adeno-associated virus (AAV) vectors carrying the murine IL-12 gene. Controlled cytokine production was achieved in vivo by using the tetracycline-inducible K19 riboswitch. AAV-mediated expression of IL-12 led to STAT4 phosphorylation, interferon-γ (IFNγ) production, infiltration of T cells and, ultimately, tumor regression. By detailed analyses of efficacy and tolerability in healthy and tumor-bearing animals, we could define a safe and efficacious vector dose. As a potential clinical candidate, we characterized vectors carrying the human IL-12 (huIL-12) gene. In mice, bioactive human IL-12 was expressed in a vector dose-dependent manner and could be induced by tetracycline, suggesting tissue-specific AAV vectors with riboswitch-controlled expression of highly potent proinflammatory cytokines as an attractive approach for vector-based cancer immunotherapy.
43
Densely Connected Convolutional Networks
Gao Huang, Zhuang Liu, Laurens van der Maaten et al. · 2017 · 44.7K citations
Amit C. Nathwani, John T. Gray, Catherine Y. Ng et al. · Blood · 2005 · 422 citations · Full text